ADMA BIOLOGICS, INC. cotiza a 10.31 USD y tiene una capitalización bursátil de $2.3B. En los últimos 12 meses ha facturado $512M con un margen de flujo de caja libre del 5.5%. Cotiza a 19.8 veces su flujo de caja libre (P/FCF) y a un PER de 13.7. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. …
| Periodo | 2026-11 | 2026-08 | 2026-05 | 2026-02 |
|---|---|---|---|---|
| Real | — | $0.17 | $0.17 | $0.22 |
| Estimado | $0.20 | $0.16 | $0.20 | $0.20 |
| Sorpresa | — | +6.3% | -15.0% | +10.0% |
| Métrica | ADMA | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 57.4% | 57.0% | +0.4% |
| Operating Margin | 37.5% | -38.6% | +76.2% |
| Net Margin | 28.8% | -33.6% | +62.4% |
| FCF Margin | 5.5% | -13.9% | +19.3% |
| ROE | 30.8% | -40.4% | +71.2% |
| ROA | 23.5% | -32.0% | +55.5% |
| Current Ratio | 6.71 | 2.84 | +3.87 |
| Debt / Equity | 0.15 | 0.28 | -0.13 |